Categorisation of HTA agencies and their decision-making systems from regulatory approval to reimbursement [Abstract]

Salek, Mir-saeed, Allen, N. and Pichler, F. 2011. Categorisation of HTA agencies and their decision-making systems from regulatory approval to reimbursement [Abstract]. International Journal of Clinical Pharmacy 33 (2) , p. 400. 10.1007/s11096-011-9481-6

Full text not available from this repository.

Abstract

All new medicines need to be granted marketing approval by a regulatory authority before they can be accessed by patients. Licensing approval is based on safety, efficacy and quality. National health providers can then decide if they should purchase the new medicine. This project aims to identify the different organisations and HTA agencies involved from the market authorisation to access of new medicines in 10 countries. This study will also produce a visual method of comparison by creating a process map for each country

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy Neuroscience and Mental Health Research Institute (NMHRI)
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Publisher:	Springer Verlag
ISSN:	2210-7703
Last Modified:	07 Feb 2022 11:01
URI:	https://orca.cardiff.ac.uk/id/eprint/32859

Citation Data

Actions (repository staff only)

Edit Item